Search

Search Constraints

You searched for: Author/Creator Degen, Olaf

Search Results

1. Aging and the evolution of comorbidities among HIV-positive individuals in a European cohort. (23rd October 2018)

2. Brief Report: Increased Frequency of CD39+ CD56bright Natural Killer Cells in HIV-1 Infection Correlates With Immune Activation and Disease Progression. (1st April 2017)

3. CD32 Expression of Different Memory T Cell Subpopulations in the Blood and Lymph Nodal Tissue of HIV Patients and Healthy Controls Correlates With Immune Activation. (1st April 2018)

4. Decreased frequency of CD73+CD8+ T cells of HIV‐infected patients correlates with immune activation and T cell exhaustion. Issue 4 (1st October 2013)

5. Deutsch‐Österreichische S2k‐Leitlinie: anale Dysplasien und Analkarzinome bei HIV‐Infizierten: Prävention, Diagnostik und Therapie. (December 2015)

8. Efficacy and Safety of Switching to the 2-Drug Regimen Dolutegravir/Lamivudine Versus Continuing a 3- or 4-Drug Regimen for Maintaining Virologic Suppression in Adults Living With Human Immunodeficiency Virus 1 (HIV-1): Week 48 Results From the Phase 3, Noninferiority SALSA Randomized Trial. (2nd March 2022)

9. German‐Austrian guidelines on anal dysplasia and anal cancer in HIV‐positive individuals: prevention, diagnosis, and treatment. (December 2015)

10. Long-acting cabotegravir plus rilpivirine for treatment in adults with HIV-1 infection: 96-week results of the randomised, open-label, phase 3 FLAIR study. Issue 4 (April 2021)